This menu provides the list of EV miRNAs identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
miRBase accession
Mature name
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Bos taurus
Homo sapiens
Mus musculus
In vitro/In vivo
Ex vivo
In vitro
By sample type
Breast cancer cells (4T1)
Breast cancer cells (MCF7)
Breast cancer cells (MDA-MB-231)
Cauda epithelial cell
Colon cancer cell (SW48)
Drug-resistant breast adenocarcinoma cell (MCF-7 MDR variant MCF-7/DX)
Leukemia cell (K562)
Liver cancer cells (MHCC-97L)
Mammary gland cells (MCF10A)
Mammary gland cells (NMuMG)
Multiple myeloma cells (U266)
By sample status
24 hr culture
72 hr culture
Normal
Survived under long-term hypoxia
Maximum false positive rate (FPR):
Maximum true positive rate (TPR):
- FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
- TPR is the percentile of miRNA among the present miRNAs.
Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.
Mature name
miRBase accession
FPR
TPR
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
hsa-miR-708-5p
MIMAT0004926
9.0e-13
4.7e-1
Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits.
Mol Cancer. 2012 Jun 8;11:37. doi: 10.1186/1476-4598-11-37.
MIPF0000397_1
15
/
0
/
15
hsa-miR-708-5p
MIMAT0004926
0.0e+0
2.4e-1
Epididymosomes convey different repertoires of microRNAs throughout the bovine epididymis.
Biol Reprod. 2013 Aug 15;89(2):30. doi: 10.1095/biolreprod.113.110486. Print 2013 Aug.
MIPF0000397_1
15
/
0
/
15
hsa-miR-708-5p
MIMAT0004926
1.3e-7
0.0e+0
Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells.
J Biol Chem. 2013 Nov 29;288(48):34343-51. doi: 10.1074/jbc.M113.480822. Epub 2013 Oct 16.
MIPF0000397_1
15
/
0
/
15
hsa-miR-708-5p
MIMAT0004926
0.0e+0
3.3e-1
Circulating exosomal microRNAs as biomarkers of colon cancer.
PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.
MIPF0000397_1
15
/
0
/
15
hsa-miR-708-5p
MIMAT0004926
9.3e-4
9.3e-4
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000397_1
15
/
0
/
15
hsa-miR-708-5p
MIMAT0004926
6.6e-9
0.0e+0
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000397_1
15
/
0
/
15
hsa-miR-708-5p
MIMAT0004926
0.0e+0
2.1e-3
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000397_1
15
/
0
/
15
hsa-miR-708-5p
MIMAT0004926
0.0e+0
4.6e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000397_1
15
/
0
/
15
hsa-miR-708-5p
MIMAT0004926
0.0e+0
1.6e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000397_1
15
/
0
/
15
hsa-miR-708-5p
MIMAT0004926
0.0e+0
1.5e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000397_1
15
/
0
/
15
hsa-miR-708-5p
MIMAT0004926
0.0e+0
2.9e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000397_1
15
/
0
/
15
hsa-miR-708-5p
MIMAT0004926
0.0e+0
4.7e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000397_1
15
/
0
/
15
hsa-miR-708-5p
MIMAT0004926
0.0e+0
2.2e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000397_1
15
/
0
/
15
hsa-miR-708-5p
MIMAT0004926
3.8e-2
3.8e-2
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000397_1
15
/
0
/
15
[1]